logo
Plus   Neg
Share
Email

Sandoz To Invest EUR 150 Mln In Austrian Facility To Strengthen Antibiotics Manufacturing

Sandoz, Novartis AG's (NVS) generics and biosimilars division, announced Monday plans for a joint investment with Austrian federal government for large-scale manufacture of active ingredients for penicillin products. The deal would strengthen antibiotics manufacturing in Europe.

Sandoz intends to invest more than 150 million euros over the next five years. The Austrian federal government would contribute or coordinate public funding totaling approximately 50 million euros towards the total investment.

Under the deal, the company plans to strengthen the long-term competitiveness of its integrated antibiotic manufacturing operations at Kundl facility in Austria, developing and introducing innovative manufacturing technology for both active pharmaceutical ingredients or APIs and finished dosage forms or FDFs.

The government funding would primarily support new process technology to produce API for penicillin products at Kundl. Sandoz would commit to related penicillin API production in Europe for the next 10 years, despite fierce global price competition, particularly from China.

The joint plan is subject to formal approvals by both parties. Sandoz and the Austrian government anticipate a formal closing of the agreement before the end of the year.

The deal is part of Austrian federal government's efforts to increase European-based production of essential medicines.

Sandoz noted that it produces enough penicillin products at Kundl to potentially meet all current Europe-wide demand.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Electric Co. filed a lawsuit against Siemens Energy AG, accusing the German power distribution company of stealing trade secrets for gas turbines. Siemens Energy allegedly used the information to get at least nine contracts to supply gas turbines to public utilities, and also covered up improper business gains. Following a court ruling, the U.S. Food and Drug Administration postponed the effective date for tobacco manufacturing companies to display new health warnings on cigarette packets and in advertisements, by additional 90 days. The warnings with color images is to promote greater public understanding of the negative health consequences of smoking. JPMorgan Chase & Co (JPM) reported strong results in the fourth quarter of 2020, with net profit up 42% largely driven by credit reserve releases of $2.9 billion. The Group said it ended the year with a CET1 ratio of 13.1% and capital above $200 billion, providing with meaningful capacity to further...
Follow RTT